Pan L, Lu MP, Wang JH, Xu M, Yang SR. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatrics: WJP Feb. 2020;16(1):19–30.
Siegel CH, Sammaritano LR. Systemic lupus erythematosus: A review. Jama May. 2024;7(17):1480–91.
Lazar S, Kahlenberg JM. Systemic lupus erythematosus: new diagnostic and therapeutic approaches. Annu Rev Med Jan. 2023;27:74:339–52.
Xu H, Zhang X, Wang X, et al. Cellular spermine targets JAK signaling to restrain cytokine-mediated autoimmunity. Immun Aug. 2024;13(8):1796–e18111798.
Peyronel F, Rossi GM, Palazzini G, et al. Early-onset lupus nephritis. Clin Kidney J Aug. 2024;17(8):sfae212.
Geng W, Zhang S, Cao J, et al. Predictive factors of psychiatric syndrome in patients with systemic lupus erythematosus. Front Immunol. 2024;15:1323209.
Article CAS PubMed PubMed Central Google Scholar
Psarras A, Wittmann M, Vital EM. Emerging concepts of type I interferons in SLE pathogenesis and therapy. Nat Rev Rheumatol Oct. 2022;18(10):575–90.
Zhou Y, Song HM. Type I interferon pathway in pediatric systemic lupus erythematosus. World J Pediatr Jul. 2024;20(7):653–68.
Qin Y, Ma J, Vinuesa CG. Monogenic lupus: insights into disease pathogenesis and therapeutic opportunities. Curr Opin Rheumatol May. 2024;1(3):191–200.
Postal M, Vivaldo JF, Fernandez-Ruiz R, Paredes JL, Appenzeller S, Niewold TB. Type I interferon in the pathogenesis of systemic lupus erythematosus. Curr Opin Immunol Dec. 2020;67:87–94.
Arish M, Sun J. Monocyte and macrophage function in respiratory viral infections. Anim Dis 2023/09/14. 2023;3(1):30.
Shen M, Duan C, Xie C, et al. Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus. Front Immunol. 2022;13:962393.
Article CAS PubMed PubMed Central Google Scholar
Perez RK, Gordon MG, Subramaniam M, et al. Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus. Sci (New York N Y) Apr. 2022;8(6589):eabf1970.
Carter LM, Wigston Z, Laws P, Vital EM. Rapid efficacy of anifrolumab across multiple subtypes of recalcitrant cutaneous lupus erythematosus parallels changes in discrete subsets of blood transcriptomic and cellular biomarkers. Br J Dermatol Jul. 2023;17(2):210–8.
Lv F, He Y, Xu H, et al. CD36 aggravates podocyte injury by activating NLRP3 inflammasome and inhibiting autophagy in lupus nephritis. Cell Death Disease Aug. 2022;23(8):729.
Tsai CY, Li KJ, Shen CY et al. Decipher the immunopathological mechanisms and set up potential therapeutic strategies for patients with lupus nephritis. Int J Mol Sci Jun 13 2023;24(12).
Kong R, Sun L, Li H, Wang D. The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease. Autoimmun Feb. 2022;55(1):1–7.
Zhang Y, Liao Y, Hang Q, Sun D, Liu Y. GBP2 acts as a member of the interferon signalling pathway in lupus nephritis. BMC Immunol Sep. 2022;17(1):44.
Liu N, Gao Y, Liu Y, Liu D. GBP5 Inhibition ameliorates the progression of lupus nephritis by suppressing NLRP3 inflammasome activation. Immunological Investigations Sep. 2022;29:1–15.
Liu J, Zhang X, Cao X. Dendritic cells in systemic lupus erythematosus: from pathogenesis to therapeutic applications. J Autoimmun Oct. 2022;132:102856.
Nehar-Belaid D, Hong S, Marches R, et al. Mapping systemic lupus erythematosus heterogeneity at the single-cell level. Nat Immunol Sep. 2020;21(9):1094–106.
Wang G, Tao H, Zhou L, et al. scRNA-seq reveals involvement of monocytes in immune response in SLE patients. Genomics Jan. 2025;14(2):110994.
Sarin KY, Zheng H, Chaichian Y et al. Impaired innate and adaptive immune responses to BNT162b2 SARS-CoV-2 vaccination in systemic lupus erythematosus. JCI Insight Mar 8 2024;9(5).
Honardoost MA, Adinatha A, Schmidt F, et al. Systematic immune cell dysregulation and molecular subtypes revealed by single-cell RNA-seq of subjects with type 1 diabetes. Genome Med Mar. 2024;27(1):45.
Kolde R, Laur S, Adler P, Vilo J. Robust rank aggregation for gene list integration and meta-analysis. Bioinf (Oxford England) Feb. 2012;15(4):573–80.
Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol Jun. 2018;36(5):411–20.
Aran D, Looney AP, Liu L, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol Feb. 2019;20(2):163–72.
Love MI, Huber W, Anders S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.
Article PubMed PubMed Central Google Scholar
Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res Apr. 2015;20(7):e47.
Van de Sande B, Flerin C, Davie K, et al. A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat Protoc Jul. 2020;15(7):2247–76.
Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinf Jan. 2013;16:14:7.
Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci United States Am Oct. 2005;25(43):15545–50.
Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols. 2009;4(1):44–57.
Spidlen J, Breuer K, Rosenberg C, Kotecha N, Brinkman RR. FlowRepository: a resource of annotated flow cytometry datasets associated with peer-reviewed publications. Cytometry Part A: J Int Soc Anal Cytol Sep. 2012;81(9):727–31.
Mokbel A, Fouad NA, Alkemary A, Abdo M. Disease activity at the onset of diagnosis as a predictor of disease outcomes in a cohort of patients with systemic lupus erythematosus: A post hoc retrospective analysis of the COMOSLE-EGYPT study. Clin Rheumatol Jan. 2025;44(1):229–35.
Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol Feb. 2002;29(2):288–91.
Ambler WG, Kaplan MJ. Vascular damage in systemic lupus erythematosus. Nat Rev Nephrol Apr. 2024;20(4):251–65.
Waterman HR, Dufort MJ, Posso SE, et al. Lupus IgA1 autoantibodies synergize with IgG to enhance plasmacytoid dendritic cell responses to RNA-containing immune complexes. Sci Transl Med Jul. 2024;3(754):eadl3848.
Infante B, Mercuri S, Dello Strologo A et al. Unraveling the link between Interferon-α and systemic lupus erythematosus: from the molecular mechanisms to target therapies. Int J Mol Sci Dec 15 2022;23(24).
Xu Y, Li P, Li K, et al. Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus. J Autoimmun Oct. 2022;132:102890.
Sim TM, Ong SJ, Mak A, Tay SH. Type I interferons in systemic lupus erythematosus: A journey from bench to bedside. Int J Mol Sci Feb 24 2022;23(5).
Sandling JK, Pucholt P, Hultin Rosenberg L, et al. Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing. Annals Rheumatic Dis Jan. 2021;80(1):109–17.
Zhang Y, Wang J, Fang Y, et al. IFN-α affects Th17/Treg cell balance through c-Maf and associated with the progression of EBV- SLE. Mol Immunol Jul. 2024;171:22–35.
Kiefer K, Oropallo MA, Cancro MP, Marshak-Rothstein A. Role of type I interferons in the activation of autoreactive B cells. Immunol Cell Biology May. 2012;90(5):498–504.
Swiecki M, Colonna M. The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol Aug. 2015;15(8):471–85.
Alculumbre S, Raieli S, Hoffmann C, Chelbi R, Danlos FX, Soumelis V. Plasmacytoid pre-dendritic cells (pDC): from molecular pathways t
Comments (0)